Noven
Executive Summary
Miami-based firm says that it is close to filing an IND for a transdermal progestogen drug delivery system for estrogen replacement therapy in postmenopausal women. The progestogen will be incorporated in Noven's interpolymeric transparent patch, which is to be worn on the lower abdomen. Noven reports discussions with several pharmaceutical companies regarding the joint development of the drug.